Clin2
NCT07533266Possibly a fitNot yet recruiting

Preventing stomach ulcers from NSAID pain relievers

NSAID (Non-Steroidal Anti-Inflammatory Drug)

Treatments studied

Part of Digestive system clinical trials.

This trial tests a new medicine, fexuprazan, to see if it can prevent stomach ulcers caused by taking NSAID pain relievers for a long time. If you need daily NSAIDs for arthritis or other muscle/bone pain, this medicine might help protect your stomach.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
360 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • You are 19 years of age or older.
  • You have a muscle, bone, or joint condition that requires daily pain relief with NSAIDs for at least 6 months.
  • You have at least one factor that raises your risk of developing stomach ulcers (like being older, having had ulcers before, or taking other medicines).
  • You have no active stomach or intestine sores (ulcers) or only healed scars from old ulcers.
  • You have not had stomach or intestinal surgery, and you have not had cancer in the last 5 years.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06284876Recruiting· Phase 3
Testing Ilaprazole for Preventing NSAID-Related Stomach Ulcers

This study tests a new medicine called Ilaprazole 10 mg to see if it can prevent stomach ulcers caused by NSAIDs (pain relievers like ibuprofen). If you take NSAIDs regularly and have a higher risk of ulcers, this trial may help protect your stomach.

Seoul
NCT07479056Recruiting
Fexuprazan to prevent stomach bleeding in heart patients on two blood thinners

This trial tests whether fexuprazan can prevent upper gastrointestinal bleeding in people at high risk who need two antiplatelet drugs for at least 6 months after a heart stent. If you are on dual antiplatelet therapy after a stent and have risk factors like older age, low weight, or history of ulcers, this study may help protect your stomach.

Seoul, Eunpyeong-gu
NCT06439563Recruiting· Phase 3
Testing JP-1366 to prevent NSAID-related stomach ulcers

This trial tests a new drug called JP-1366 to see if it can prevent stomach ulcers caused by long-term NSAID use (like ibuprofen or naproxen) for conditions such as arthritis. It may be a good fit if you need to take NSAIDs for at least 24 weeks and have a higher risk of ulcers.

Seoul
NCT07558707Not yet recruiting
Fexuclue for preventing NSAID-related stomach ulcers in everyday use

This study tests a medication called Fexuclue to see how well it prevents stomach ulcers in people who take NSAIDs (common pain relievers) for conditions like arthritis or chronic pain. If you need long-term NSAID therapy, this treatment might help protect your stomach.

Seoul
NCT06948487Recruiting
Study of Fexuclu tablets for stomach inflammation (gastritis)

This study watches patients with acute or chronic gastritis who are already being prescribed the stomach medicine Fexuclu (fexuprazan). It collects information to see how well the medicine works and if it causes any side effects in everyday use.

Seoul
NCT07471867Recruiting· Phase 4
Testing a new stomach medicine for heart patients on clopidogrel

This trial tests if a new stomach acid medicine (Zastaprazan) affects how well clopidogrel works in heart patients who have had a stent placed. It aims to help people who need both clopidogrel and a stomach acid drug after a procedure.

Yongin-si, Gyeonggi-do

Hear when a new NSAID (Non-Steroidal Anti-Inflammatory Drug) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.